PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
PROTECT Pilot objective is to assess: 1) the feasibility of timely enrollment and complete,
blinded study drug administration, 2) the bioaccumulation of LMWH in patients with acquired
renal insufficiency and its association with bleeding, 3) the feasibility of scheduled twice
weekly lower limb ultrasounds, and 4) recruitment rates for a future randomized trial.
Phase:
Phase 3
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborators:
Canadian Critical Care Trials Group Canadian Institutes of Health Research (CIHR)